PVLA: FDA Grants Rolling Review
Palvella's QTORIN Rapamycin NDA for Microcystic Lymphatic Malformations receives rolling review from FDA
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.